Your browser doesn't support javascript.
loading
Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma.
Puerto-Camacho, Pilar; Amaral, Ana Teresa; Lamhamedi-Cherradi, Salah-Eddine; Menegaz, Brian A; Castillo-Ecija, Helena; Ordóñez, José Luis; Domínguez, Saioa; Jordan-Perez, Carmen; Diaz-Martin, Juan; Romero-Pérez, Laura; Lopez-Alvarez, Maria; Civantos-Jubera, Gema; Robles-Frías, María José; Biscuola, Michele; Ferrer, Cristina; Mora, Jaume; Cuglievan, Branko; Schadler, Keri; Seifert, Oliver; Kontermann, Roland; Pfizenmaier, Klaus; Simón, Laureano; Fabre, Myriam; Carcaboso, Ángel M; Ludwig, Joseph A; de Álava, Enrique.
Afiliação
  • Puerto-Camacho P; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Amaral AT; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Lamhamedi-Cherradi SE; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Menegaz BA; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Castillo-Ecija H; Institut de Recerca Sant Joan de Déu, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu Barcelona, Spain.
  • Ordóñez JL; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Domínguez S; Oncomatryx, Derio, Bilbao, Spain.
  • Jordan-Perez C; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Diaz-Martin J; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Romero-Pérez L; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Lopez-Alvarez M; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Civantos-Jubera G; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Robles-Frías MJ; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Biscuola M; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Ferrer C; Oncomatryx, Derio, Bilbao, Spain.
  • Mora J; Institut de Recerca Sant Joan de Déu, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu Barcelona, Spain.
  • Cuglievan B; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Schadler K; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Seifert O; IZI, University of Stuttgart, Germany.
  • Kontermann R; IZI, University of Stuttgart, Germany.
  • Pfizenmaier K; IZI, University of Stuttgart, Germany.
  • Simón L; Oncomatryx, Derio, Bilbao, Spain.
  • Fabre M; Oncomatryx, Derio, Bilbao, Spain.
  • Carcaboso ÁM; Institut de Recerca Sant Joan de Déu, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu Barcelona, Spain.
  • Ludwig JA; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. enrique.alava.sspa@juntadeandalucia.es jaludwig@mdanderson.org.
  • de Álava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain. enrique.alava.sspa@juntadeandalucia.es jaludwig@mdanderson.org.
Clin Cancer Res ; 25(7): 2228-2240, 2019 04 01.
Article em En | MEDLINE | ID: mdl-30420447
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma de Ewing / Neoplasias Ósseas / Imunoconjugados / Endoglina / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma de Ewing / Neoplasias Ósseas / Imunoconjugados / Endoglina / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha